A Phase 1 Bioequivalence Study of a Test Tablet Formulation of Ravidasvir With the Reference Tablet Formulation of Ravidasvir Study
Clinical trial NCT03602300 · COMPLETED
Trial details
- NCT number
- NCT03602300
- Sponsor
- Drugs for Neglected Diseases
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-05
- Primary completion
- 2018-08-17
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.